Health & Fitness
Thu, April 26, 2012Wed, April 25, 2012Tue, April 24, 2012Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
//health-fitness.news-articles.net/content/2012/ .. resent-first-quarter-2012-financial-results.html
Published in Health and Fitness on Wednesday, April 25th 2012 at 13:46 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012... -- SAN DIEGO, April 25, 2012 /PRNewswire/ --
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
CONFERENCE CALL AND WEBCAST SCHEDULED FOR WEDNESDAY, MAY 2, 2012
SAN DIEGO, April 25, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that the Company will report its first quarter 2012 financial results after the Nasdaq market closes on Wednesday, May 2, 2012. Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, May 2, 2012 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
Participants can access the live conference call by dialing 800-894-5910, (US) or 785-424-1052 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at [ http://www.neurocrine.com ]
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 800-753-8878 (US) or 402-220-0688 (International) using the conference ID: NBIX. The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].
SOURCE Neurocrine Biosciences, Inc.
[ Back to top ] RELATED LINKS
[ http://www.neurocrine.com ]